References
- Kager L, Nord C E. Imipenem/cilastatin in the treatment of intraabdominal infections: a review of world experience. Rev Infect Dis 1985; 7(Suppl 3)518–521
- Ubukata K, Hikida M, Yoshida M, Noshiki Y, Furukawa K, Tashiro M, Konno M, Mitsuhashi S. In vitro activity of LJC 10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob Agents Chemother 1990; 34: 994–1000
- Yoshida M, Mitsuhashi S. In vitro antibacterial activity and β-lactamase stability of the new carbapenem LJC 10,627. Eur J Clin Microbiol infect Dis 1990; 9: 625–629
- Nord C E, Lindmark A, Persson I. In vitro activity of L-627 against anaerobic bacteria. Eur J Clin Microbiol Infect Dis 1992; 11: 757–760
- Nord C E, Lahnborg G. Biapenem versus gentamicin plus metronidazole in the treatment of experimental intraabdominal infections. Recent advances in chemotherapy. American Society for Microbiology, Washington, DC 1994; 506–507
- Solomkin J S, Hemsell D L, Sweet R, Tally F, Bartlett J. Evaluation of new anti-infective drugs for the treatment of intra-abdominal infections. Clin Infect Dis 1992; 15(Suppl 1)S33–S42
- Knaus W A, Draper E A, Wagner D P, Zimmerman J E. APACHE II: a severity of disease classification system. Critical Care Med 1985; 13: 818–829
- Ericsson H, Sherris J C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand 1971; 3–90, (Suppl 217)
- Solomkin J S, Dellinger E P, Christou N V, Busuttil R W. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 1990; 212: 581–591
- Brismar B, Malmborg A S, Tunevall G, Wretlind B, Bergman L, Mentzing L O, Nyström P O, Kihlström E, Bäckstrand B, Skau T, Kasholm-Tengve B, Sjöberg L, Olsson-Liljequist B, Tally F P, Gatenbeck L, Eklund A E, Nord C E. Piperacillintazobactam versus imipenem–cilastatin for treatment of intraabdominal infections. Antimicrob Agents Chemother 1992; 36: 2766–2773
- Swedish Study Group. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. J Antimicrob Chemother 1995; 35: 139–148
- Ohmann C, Wittmann D H, Wacha A. The Peritonitis Study Group Prospective evaluation of prognostic scoring systems in peritonitis. Eur J Surg 1993; 159: 267–274
- Cooper G S, Shlaes D M, Salata R A. Intraabdominal infections: Differences in presentation and outcome between younger patients and elderly. Clin Infect Dis 1994; 19: 146–148